Published in Stroke on June 10, 2004
Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am (2010) 1.53
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Cerebral venous-sinus thrombosis: a case series analysis. Iran J Med Sci (2011) 1.06
Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke (2010) 0.96
Clinical profile and outcome of cerebral venous sinus thrombosis at tertiary care center. J Neurosci Rural Pract (2014) 0.90
Cerebral venous thrombosis in the mediterranean area in children. Mediterr J Hematol Infect Dis (2011) 0.85
Stroke and nutrition: a review of studies. Int J Prev Med (2013) 0.83
Increased levels of homocysteine in patients with ulcerative colitis. World J Gastroenterol (2010) 0.81
Hyperhomocysteinemia in ulcerative colitis is related to folate levels. World J Gastroenterol (2005) 0.80
A young man with deep vein thrombosis, hyperhomocysteinemia and cobalamin deficiency. CMAJ (2008) 0.78
Hyperhomocysteinemia, low vitamin B12, and low folic acid: Are risk factors of cerebral vascular thrombosis in northwest Iran? J Res Med Sci (2016) 0.75
Cerebral Venous Thrombosis and Livedo Reticularis in a Case with MTHFR 677TT Homozygote. J Clin Neurol (2006) 0.75
A rare localization of cerebral venous sinus thrombosis. Case report. G Chir (2015) 0.75
Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis. Front Neurol (2015) 0.75
Oral contraceptive induced cerebral venous thrombosis treated by local catheter directed thrombolysis. Interv Neuroradiol (2005) 0.75
Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study. J Res Med Sci (2015) 0.75
Association study of methylenetetrahydrofolate reductase A1298C mutation with cerebral venous thrombosis risk in an Iranian population. Int J Appl Basic Med Res (2015) 0.75
Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke (2004) 8.77
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30
Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke (2010) 3.53
Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke (2003) 2.63
Causes and predictors of death in cerebral venous thrombosis. Stroke (2005) 2.56
Intellectual function in Mexican children living in a mining area and environmentally exposed to manganese. Environ Health Perspect (2010) 1.80
Cerebral venous and sinus thrombosis in women. Stroke (2009) 1.61
Dissection of cervical arteries: Long-term follow-up study of 130 consecutive cases. Cerebrovasc Dis (2006) 1.60
Proinflammatory and cytotoxic effects of Mexico City air pollution particulate matter in vitro are dependent on particle size and composition. Environ Health Perspect (2003) 1.45
[Systolic blood pressure and functional outcome in patients with acute stroke: a Mexican registry of acute cerebrovascular disease (RENAMEVASC)]. Arch Cardiol Mex (2011) 1.43
Biologic effects induced in vitro by PM10 from three different zones of Mexico City. Environ Health Perspect (2002) 1.41
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke (2011) 1.39
Motor alterations associated with exposure to manganese in the environment in Mexico. Sci Total Environ (2006) 1.22
Cadmium neurotoxicity. Environ Toxicol Pharmacol (2006) 1.19
Venous thromboembolic events after cerebral vein thrombosis. Stroke (2010) 1.13
Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke (2007) 1.13
Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases. Stroke (2003) 1.10
The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact (2010) 1.04
Induction of IL-6 and inhibition of IL-8 secretion in the human airway cell line Calu-3 by urban particulate matter collected with a modified method of PM sampling. Environ Res (2009) 1.03
Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke (2008) 1.02
Juvenile myoclonic epilepsy: linkage to chromosome 6p12 in Mexico families. Am J Med Genet (2002) 1.02
Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxid Med Cell Longev (2013) 1.00
Biomarkers of manganese exposure in a population living close to a mine and mineral processing plant in Mexico. Environ Res (2007) 0.99
Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis (2009) 0.97
Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation. Neurochem Res (2004) 0.97
Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke (2010) 0.96
Manganese accumulation in the CNS and associated pathologies. Biometals (2011) 0.96
Severe cysticercal meningitis: clinical and imaging characteristics. Am J Trop Med Hyg (2010) 0.94
Are steroids useful to treat cerebral venous thrombosis? Stroke (2007) 0.92
Cerebral vein and dural sinus thrombosis in elderly patients. Stroke (2005) 0.91
Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res (2002) 0.90
Constitutive and inducible nitric oxide synthase activities after spinal cord contusion in rats. Neurosci Lett (2002) 0.90
Cognitive impairment in an adult Mexican population non-occupationally exposed to manganese. Environ Toxicol Pharmacol (2009) 0.89
Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.87
Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke (2009) 0.87
Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis (2013) 0.87
Modelling the biphasic growth and product formation by Enterococcus faecium CECT 410 in realkalized fed-batch fermentations in whey. J Biomed Biotechnol (2010) 0.87
Early metabolic reactivation versus antioxidant therapy after a traumatic spinal cord injury in adult rats. Neuropathology (2009) 0.86
In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. J Hepatol (2010) 0.85
Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats. J Neurosci Res (2008) 0.84
Lead neurotoxicity: effects on brain nitric oxide synthase. J Mol Histol (2012) 0.84
Hypothyroidism induces selective oxidative stress in amygdala and hippocampus of rat. Metab Brain Dis (2008) 0.83
Spinal nerve ligation reduces nitric oxide synthase activity and expression: effect of resveratrol. Pharmacol Biochem Behav (2008) 0.83
Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats. Neurochem Res (2006) 0.83
Possible mechanisms of neurodegeneration in schizophrenia. Neurochem Res (2006) 0.83
Cyclosporin-A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expressions after spinal cord injury in rats. Neurochem Res (2005) 0.83
Induction of ferroxidase enzymatic activity by copper reduces MPP+-evoked neurotoxicity in rats. Neurosci Res (2013) 0.83
Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma. J Neurosurg (2006) 0.83
Brain regional lipid peroxidation and metallothionein levels of developing rats exposed to cadmium and dexamethasone. Toxicol Lett (2003) 0.82
Tissue spinal cord response in rats after implants of polypyrrole and polyethylene glycol obtained by plasma. J Mater Sci Mater Med (2007) 0.82
Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study. Genes Nutr (2011) 0.82
Predictive factors for intracerebral hemorrhage in patients with cavernous angiomas. Neurol Res (2005) 0.81
Genetic admixture of European FRDA genes is the cause of Friedreich ataxia in the Mexican population. Genomics (2004) 0.81
Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale. Int J Stroke (2011) 0.80
Prognosis of cerebral vein thrombosis presenting as isolated headache: early vs. late diagnosis. Cephalalgia (2012) 0.80
Cyclosporin-A inhibits inducible nitric oxide synthase activity and expression after spinal cord injury in rats. Neurosci Lett (2004) 0.80
Feasibility of in vivo quantitative magnetic resonance imaging with diffusion weighted imaging, T2-weighted relaxometry, and diffusion tensor imaging in a clinical 3 tesla magnetic resonance scanner for the acute traumatic spinal cord injury of rats: technical note. Spine (Phila Pa 1976) (2013) 0.80
Urban dust fecal pollution in Mexico City: antibiotic resistance and virulence factors of Escherichia coli. Int J Hyg Environ Health (2006) 0.79
Delayed effects of thallium in the rat brain: regional changes in lipid peroxidation and behavioral markers, but moderate alterations in antioxidants, after a single administration. Food Chem Toxicol (2005) 0.79
Cognitive deficits in adult rats by lead intoxication are related with regional specific inhibition of cNOS. Behav Brain Res (2004) 0.79
Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection. Cerebrovasc Dis (2007) 0.79
Alterations induced by chronic lead exposure on the cells of circadian pacemaker of developing rats. Int J Exp Pathol (2011) 0.79
Cerebral venous thrombosis with nonhemorrhagic lesions: clinical correlates and prognosis. Cerebrovasc Dis (2010) 0.79
Liquid chromatographic-fluorimetric method for the estimation of nitric oxide biosynthesis in the central nervous system. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.78
Nitric oxide synthase immunolocalization and expression in the rat hippocampus after sub-acute lead acetate exposure in rats. Exp Toxicol Pathol (2009) 0.78
Antioxidant properties of xanthones from Calophyllum brasiliense: prevention of oxidative damage induced by FeSO₄. BMC Complement Altern Med (2013) 0.78
Potential toxic effects associated to metals and endotoxin present in PM10: an ancillary study using multivariate analysis. Inhal Toxicol (2007) 0.78
Effect of thalidomide in different tumors in rodents. J Exp Ther Oncol (2002) 0.78
Morphological changes of rat astrocytes induced by liver damage but not by manganese chloride exposure. Metab Brain Dis (2009) 0.78
Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease. BMC Med Genet (2010) 0.78
Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med (2003) 0.78
Cognitive impairment and mortality in older healthy Mexican subjects: a population-based 10-year follow-up study. Neurol Res (2005) 0.77
[Obesity paradox and functional recovery in first-ever acute ischemic stroke survivors: the PREMIER study]. Rev Neurol (2010) 0.77
Characterization of Escherichia coli Isolates from an Urban Lake Receiving Water from a Wastewater Treatment Plant in Mexico City: Fecal Pollution and Antibiotic Resistance. Curr Microbiol (2015) 0.77
Acute dehydroepiandrosterone treatment exerts different effects on dopamine and serotonin turnover ratios in the rat corpus striatum and nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.76
Lipid peroxidation by nitric oxide supplements after spinal cord injury: effect of antioxidants in rats. Neurosci Lett (2002) 0.76
Sub-chronic copper pretreatment reduces oxidative damage in an experimental Huntington's disease model. Biol Trace Elem Res (2014) 0.76
Nitric oxide production in striatum and pallidum of cirrhotic rats. Neurochem Res (2006) 0.76
Delayed administration of dapsone protects from tissue damage and improves recovery after spinal cord injury. J Neurosci Res (2011) 0.76
Inhibitory effect of dehydroepiandrosterone on brain monoamine oxidase activity: in vivo and in vitro studies. Life Sci (2009) 0.76
CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas. Pharmacogenomics (2014) 0.76
Plasma polypyrrole implants recover motor function in rats after spinal cord transection. J Mater Sci Mater Med (2012) 0.76
Manganese and ammonia interactions in the brain of cirrhotic rats: effects on brain ammonia metabolism. Neurochem Res (2012) 0.76
Functional recovery in spinal cord injured rats using polypyrrole/iodine implants and treadmill training. J Mater Sci Mater Med (2015) 0.75
Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial. Neurol Sci (2011) 0.75
Arginine, citrulline and nitrate concentrations in the cerebrospinal fluid from patients with acute hydrocephalus. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Plasma taurine as a predictor of poor outcome in patients with mild neurological deficits after aneurysmal subarachnoid hemorrhage. J Neurosurg (2013) 0.75
Copper sulfate prevents tyrosine hydroxylase reduced activity and motor deficits in a Parkinson's disease model in mice. Rev Invest Clin (2010) 0.75
Reply to comment on: "Assessment of nitric oxide biosynthesis and peroxynitrite formation within the central nervous system by measuring L-citrulline in the cerebrospinal fluid?". J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.75
Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study. Neurol Res (2007) 0.75
[Guideline for hypertension treatment in patients with cerebrovascular diseases after acute phase]. Rev Invest Clin (2010) 0.75
[Statins for the secondary prevention of ischemic stroke]. Rev Invest Clin (2010) 0.75
Activation of heme oxygenase recovers motor function after spinal cord injury in rats. Neurosci Lett (2013) 0.75
[Guideline for secondary prevention treatment in cerebrovascular diseases after acute phase]. Rev Invest Clin (2010) 0.75
[Antiocoagulation for the secondary prevention of ischemic stroke]. Rev Invest Clin (2010) 0.75
[Primary prevention of cerebrovascular disease]. Rev Invest Clin (2002) 0.75
[Lifestye and primary and secondary prevention for cerebrovascular disease]. Rev Invest Clin (2010) 0.75
[Guideline for surgical treatment (endarterectomy) and endovascular (angioplasty with distal protection and stenting) for secondary prevention treatment of ischemic stroke secondary to carotid atheroesclerotic disease]. Rev Invest Clin (2010) 0.75